Lighthouse Investment Partners LLC raised its holdings in shares of The Chemours Company (NYSE:CC – Free Report) by 241.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 89,854 shares of the specialty chemicals company’s stock after acquiring an additional 63,566 shares during the quarter. Lighthouse Investment Partners LLC’s holdings in Chemours were worth $1,519,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of CC. Norges Bank purchased a new position in Chemours during the 4th quarter valued at about $30,702,000. Bank of Montreal Can lifted its holdings in shares of Chemours by 1,496.4% during the 4th quarter. Bank of Montreal Can now owns 953,240 shares of the specialty chemicals company’s stock valued at $16,110,000 after buying an additional 893,530 shares during the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Chemours by 23.8% during the 4th quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company’s stock valued at $73,907,000 after buying an additional 839,849 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Chemours by 141.5% during the 4th quarter. Invesco Ltd. now owns 1,020,001 shares of the specialty chemicals company’s stock valued at $17,238,000 after buying an additional 597,638 shares during the last quarter. Finally, Covalis Capital LLP acquired a new stake in shares of Chemours during the 4th quarter valued at about $8,768,000. Hedge funds and other institutional investors own 76.26% of the company’s stock.
Analysts Set New Price Targets
CC has been the subject of several research reports. Mizuho set a $15.00 price target on Chemours in a report on Tuesday, April 15th. Barclays reduced their price target on Chemours from $19.00 to $16.00 and set an “equal weight” rating for the company in a report on Tuesday, April 1st. BMO Capital Markets reduced their price target on Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a report on Wednesday, February 19th. Morgan Stanley reduced their price target on Chemours from $22.00 to $15.00 and set an “equal weight” rating for the company in a report on Monday. Finally, StockNews.com lowered Chemours from a “hold” rating to a “sell” rating in a report on Thursday, May 8th. One analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $18.33.
Chemours Stock Down 1.7%
CC opened at $11.79 on Wednesday. The business has a 50 day moving average price of $12.47 and a 200 day moving average price of $16.43. The Chemours Company has a twelve month low of $9.33 and a twelve month high of $29.18. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The firm has a market cap of $1.76 billion, a P/E ratio of 20.68 and a beta of 1.76.
Chemours (NYSE:CC – Get Free Report) last posted its earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.06). Chemours had a return on equity of 26.54% and a net margin of 1.51%. The company had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.36 billion. During the same quarter last year, the firm posted $0.32 earnings per share. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. Research analysts forecast that The Chemours Company will post 2.03 EPS for the current year.
Chemours Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.48%. Chemours’s dividend payout ratio (DPR) is presently 175.00%.
About Chemours
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Recommended Stories
- Five stocks we like better than Chemours
- Learn Technical Analysis Skills to Master the Stock Market
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Why Boeing May Be Ready to Take Off After Latest Developments
- What is the Hang Seng index?
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CC – Free Report).
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.